Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07840001 |
| Title | Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma (NEBULA) |
| Acronym | NEBULA |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Peter MacCallum Cancer Centre, Australia |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Peter MacCallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details |